Sign In

Login

Password

Forgot Password ? Sign Up

AREDS (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "AREDS" in German language version.

refsWebsite
Global rank German rank
5doi.org
2nd place
3rd place
5nih.gov
4th place
7th place
1web.archive.org
1st place
1st place

doi.org

  • Age-Related Eye Disease Study Research Group: A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. In: Archives of Ophthalmology (Chicago, Ill.: 1960). Band 119, Nr. 10, Oktober 2001, S. 1417–1436, doi:10.1001/archopht.119.10.1417, PMID 11594942, PMC 1462955 (freier Volltext) – (englisch).
  • Johanna M. Seddon et al.: Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis. In: The British Journal of Ophthalmology. Band 100, Nr. 12, Dezember 2016, S. 1731–1737, doi:10.1136/bjophthalmol-2016-308624, PMID 27471039, PMC 6570490 (freier Volltext) – (englisch).
  • Demetrios G. Vavvas et al.: CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation. In: Proceedings of the National Academy of Sciences of the United States of America. Band 115, Nr. 4, 23. Januar 2018, S. E696–E704, doi:10.1073/pnas.1718059115, PMID 29311295, PMC 5789949 (freier Volltext) – (englisch).
  • Age-Related Eye Disease Study 2 Research Group: Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. In: JAMA. Band 309, Nr. 19, 15. Mai 2013, S. 2005–2015, doi:10.1001/jama.2013.4997, PMID 23644932 (englisch).
  • Jennifer R. Evans, John G. Lawrenson: Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. In: The Cochrane Database of Systematic Reviews. Band 7, 31. Juli 2017, S. CD000254, doi:10.1002/14651858.CD000254.pub4, PMID 28756618, PMC 6483465 (freier Volltext) – (englisch).

nih.gov

ncbi.nlm.nih.gov

  • Age-Related Eye Disease Study Research Group: A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. In: Archives of Ophthalmology (Chicago, Ill.: 1960). Band 119, Nr. 10, Oktober 2001, S. 1417–1436, doi:10.1001/archopht.119.10.1417, PMID 11594942, PMC 1462955 (freier Volltext) – (englisch).
  • Johanna M. Seddon et al.: Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis. In: The British Journal of Ophthalmology. Band 100, Nr. 12, Dezember 2016, S. 1731–1737, doi:10.1136/bjophthalmol-2016-308624, PMID 27471039, PMC 6570490 (freier Volltext) – (englisch).
  • Demetrios G. Vavvas et al.: CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation. In: Proceedings of the National Academy of Sciences of the United States of America. Band 115, Nr. 4, 23. Januar 2018, S. E696–E704, doi:10.1073/pnas.1718059115, PMID 29311295, PMC 5789949 (freier Volltext) – (englisch).
  • Age-Related Eye Disease Study 2 Research Group: Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. In: JAMA. Band 309, Nr. 19, 15. Mai 2013, S. 2005–2015, doi:10.1001/jama.2013.4997, PMID 23644932 (englisch).
  • Jennifer R. Evans, John G. Lawrenson: Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. In: The Cochrane Database of Systematic Reviews. Band 7, 31. Juli 2017, S. CD000254, doi:10.1002/14651858.CD000254.pub4, PMID 28756618, PMC 6483465 (freier Volltext) – (englisch).

web.archive.org